a public good project by the
Synthesis
Company
of California

© 2026

Shigeru Okuyama | doi.page

0 works0 citations0 h-index

Shigeru Okuyama

Taisho Pharmaceutical (Japan)(JP)Taisho Pharmaceutical (Japan)(JP)

Publications by Year

Research Areas

Neuroscience and Neuropharmacology Research, Receptor Mechanisms and Signaling, Pharmacological Receptor Mechanisms and Effects, Neuropeptides and Animal Physiology, Neurotransmitter Receptor Influence on Behavior

Most-Cited Works

→ Epilepsy and Exacerbation of Brain Injury in Mice Lacking the Glutamate Transporter GLT-1(1997)1,758 cited
→ Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor(1995)861 cited
→ Motor discoordination and increased susceptibility to cerebellar injury in GLAST mutant mice(1998)408 cited
→ Functions of the two glutamate transporters GLAST and GLT-1 in the retina(1998)254 cited
→ MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity(2003)250 cited
→ Modification of Glial–Neuronal Cell Interactions Prevents Photoreceptor Apoptosis during Light-Induced Retinal Degeneration(2000)220 cited

→ Design, synthesis and structure–affinity relationships of aryloxyanilide derivatives as novel peripheral benzodiazepine receptor ligands(2003)157 cited

→ Receptor Binding, Behavioral, and Electrophysiological Profiles of Nonpeptide Corticotropin-Releasing Factor Subtype 1 Receptor Antagonists CRA1000 and CRA1001(1999)153 cited

→ Anxiolytic- and Antidepressant-Like Profile of ATC0065 and ATC0175: Nonpeptidic and Orally Active Melanin-Concentrating Hormone Receptor 1 Antagonists(2005)132 cited

→ Anxiety-like behavior in mice lacking the angiotensin II type-2 receptor(1999)119 cited